Search Results - "Tribble, James R."
-
1
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Published in Redox biology (01-07-2021)“…Nicotinamide adenine dinucleotide (NAD) is a REDOX cofactor and metabolite essential for neuronal survival. Glaucoma is a common neurodegenerative disease in…”
Get full text
Journal Article -
2
Sholl analysis: A quantitative comparison of semi-automated methods
Published in Journal of neuroscience methods (30-03-2014)“…•We compare four Sholl analysis methods to the manual method.•We validate two Sholl analysis methods.•We highlight two errors in two Sholl analysis methods…”
Get full text
Journal Article -
3
Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Published in Molecular neurodegeneration (06-04-2016)“…Glaucoma is a complex, multifactorial disease characterised by the loss of retinal ganglion cells and their axons leading to a decrease in visual function. The…”
Get full text
Journal Article -
4
Protrudin functions from the endoplasmic reticulum to support axon regeneration in the adult CNS
Published in Nature communications (05-11-2020)“…Adult mammalian central nervous system axons have intrinsically poor regenerative capacity, so axonal injury has permanent consequences. One approach to…”
Get full text
Journal Article -
5
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production
Published in Nature communications (17-09-2024)Get full text
Journal Article -
6
Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J mice
Published in Molecular brain (25-05-2020)“…Glaucoma is the leading cause of irreversible vision loss. Ocular hypertension is a major risk factor for glaucoma and recent work has demonstrated critical…”
Get full text
Journal Article -
7
NMNAT2 is a druggable target to drive neuronal NAD production
Published in Nature communications (24-07-2024)“…Maintenance of NAD pools is critical for neuronal survival. The capacity to maintain NAD pools declines in neurodegenerative disease. We identify that low…”
Get full text
Journal Article -
8
Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients
Published in Acta neuropathologica communications (19-08-2022)“…Neuroinflammation is recognized as a key component of neurodegenerative disease. In glaucoma, a common neurodegenerative disease and the leading cause of…”
Get full text
Journal Article -
9
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve
Published in Acta neuropathologica communications (22-01-2023)“…Glaucoma is the leading cause of irreversible blindness and is a major health and economic burden. Current treatments do not address the neurodegenerative…”
Get full text
Journal Article -
10
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Published in Acta neuropathologica communications (23-08-2024)“…A compromised capacity to maintain NAD pools is recognized as a key underlying pathophysiological feature of neurodegenerative diseases. NAD acts as a…”
Get full text
Journal Article -
11
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume
Published in Acta neuropathologica communications (01-03-2024)“…Leber's hereditary optic neuropathy (LHON) is driven by mtDNA mutations affecting Complex I presenting as progressive retinal ganglion cell dysfunction usually…”
Get full text
Journal Article -
12
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
Published in Cells (Basel, Switzerland) (01-02-2021)“…Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive dysfunction and death of retinal ganglion cells occurs, eliminating transfer of…”
Get full text
Journal Article -
13
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection
Published in Acta neuropathologica communications (21-05-2024)“…Neurodegenerative diseases have common underlying pathological mechanisms including progressive neuronal dysfunction, axonal and dendritic retraction, and…”
Get full text
Journal Article -
14
Glial metabolic alterations during glaucoma pathogenesis
Published in Frontiers in ophthalmology (2023)“…Glaucoma is the leading cause of irreversible blindness. Current treatment options are limited and often only slow disease progression. Metabolic dysfunction…”
Get full text
Journal Article -
15
Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection
Published in Acta neuropathologica communications (08-09-2023)“…Abstract Retinal ganglion cells are highly metabolically active requiring strictly regulated metabolism and functional mitochondria to keep ATP levels in…”
Get full text
Journal Article -
16
Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model
Published in Frontiers in cell and developmental biology (12-05-2022)“…Neuroinflammation is a critical and targetable pathogenic component of neurodegenerative diseases, including glaucoma, the leading cause of irreversible…”
Get full text
Journal Article -
17
Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
Published in Brain communications (01-01-2019)“…Glaucoma is characterized by the progressive dysfunction and loss of retinal ganglion cells. However, the earliest degenerative events that occur in human…”
Get full text
Journal Article -
18
Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma
Published in Molecular brain (21-11-2018)“…Retinal ganglion cell dendritic atrophy is an early feature of glaucoma, and the recovery of retinal ganglion cell dendrites is a viable option for vision…”
Get full text
Journal Article -
19
Microbead models in glaucoma
Published in Experimental eye research (01-12-2015)“…The sustained and moderate elevation of intraocular pressure, which can be initiated at precise time points, remains the cornerstone of research into the…”
Get full text
Journal Article -
20
Preventing retinal homocysteine dysregulation protects against retinal ganglion cell death
Published in Acta ophthalmologica (Oxford, England) (01-01-2024)“…Glaucoma, the most common cause of irreversible blindness, is characterized by progressive dysfunction and loss of retinal ganglion cells. There are no…”
Get full text
Journal Article